Your browser doesn't support javascript.
loading
Increased proportions of γδ T lymphocytes in atypical SCID associate with disease manifestations.
Tometten, Inga; Felgentreff, Kerstin; Hönig, Manfred; Hauck, Fabian; Albert, Michael H; Niehues, Tim; Perez, Ruy; Ghosh, Sujal; Picard, Capucine; Stary, Jan; Formankova, Renata; Worth, Austen; Soler-Palacín, Pere; García-Prat, Marina; Allende, Luis M; Gonzalez-Granado, Luis Ignacio; Stepensky, Polina; Di Cesare, Silvia; Scarselli, Alessia; Cancrini, Caterina; Speckmann, Carsten; Gilmour, Kimberly; Notarangelo, Luigi; Ehl, Stephan; Rohr, Jan C.
Afiliación
  • Tometten I; Center for Chronic Immunodeficiency, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
  • Felgentreff K; Department of Pediatrics and Adolescent Medicine, Ulm University, Ulm, Germany.
  • Hönig M; Department of Pediatrics and Adolescent Medicine, Ulm University, Ulm, Germany.
  • Hauck F; Department of Pediatrics, Dr. von Hauner Children's Hospital, University Hospital, LMU, Munich, Germany.
  • Albert MH; Department of Pediatrics, Dr. von Hauner Children's Hospital, University Hospital, LMU, Munich, Germany.
  • Niehues T; HELIOS Children's Hospital Krefeld, Pediatric Immunology and Rheumatology, Krefeld, Germany.
  • Perez R; HELIOS Children's Hospital Krefeld, Pediatric Immunology and Rheumatology, Krefeld, Germany.
  • Ghosh S; Department of Pediatric Oncology, Hematology and Clinical Immunology, Medical Faculty, Center of Child and Adolescent Health, Heinrich-Heine-University, Dusseldorf, Germany.
  • Picard C; Paris Descartes-Sorbonne Paris Cité University, Imagine Institute Paris, Paris, France; Paediatric Haematology-Immunology and Rheumatology Unit, Necker-Enfants Malades Hospital, Assistance Publique-Hôpitaux de Paris (APHP), Paris, France; Center for Primary Immunodeficiencies, Necker-Enfants Malades
  • Stary J; Department of Pediatric Hematology and Oncology, Charles University and University Hospital Motol, Prague, Czech Republic.
  • Formankova R; Department of Pediatric Hematology and Oncology, Charles University and University Hospital Motol, Prague, Czech Republic.
  • Worth A; Great Ormond Street Hospital NHS Trust, London, United Kingdom.
  • Soler-Palacín P; Pediatric Infectious Diseases and Immunodeficiencies Unit (UPIIP), Hospital Universitari Vall d'Hebron (HUVH), Vall d'Hebron Research Institute (VHIR), Universitat Autònoma de Barcelona (UAB), Barcelona, Spain; Jeffrey Model Foundation Excellence Center, Barcelona, Spain.
  • García-Prat M; Pediatric Infectious Diseases and Immunodeficiencies Unit (UPIIP), Hospital Universitari Vall d'Hebron (HUVH), Vall d'Hebron Research Institute (VHIR), Universitat Autònoma de Barcelona (UAB), Barcelona, Spain; Jeffrey Model Foundation Excellence Center, Barcelona, Spain.
  • Allende LM; Immunology Department, Hospital Universitario 12 de Octubre, Research Institute (i+12). Madrid, Spain.
  • Gonzalez-Granado LI; Immunodeficiencies Unit, Department of Pediatrics, University Hospital 12 de Octubre, Research Institute Hospital 12 Octubre (i+12), Madrid, Spain; Complutense University of Madrid, Madrid, Spain.
  • Stepensky P; Department of Bone Marrow Transplantation, Hadassah Hebrew University Medical Center, Jerusalem, Israel.
  • Di Cesare S; University Department of Pediatrics, Unit of Immune and Infectious Diseases, Children's Hospital Bambino Gesù, Rome, Italy.
  • Scarselli A; University Department of Pediatrics, Unit of Immune and Infectious Diseases, Children's Hospital Bambino Gesù, Rome, Italy.
  • Cancrini C; University Department of Pediatrics, Unit of Immune and Infectious Diseases, Children's Hospital Bambino Gesù, Rome, Italy; Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy.
  • Speckmann C; Center for Chronic Immunodeficiency, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany; Center for Pediatrics and Adolescent Medicine, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
  • Gilmour K; Great Ormond Street Hospital NHS Trust, London, United Kingdom.
  • Notarangelo L; Laboratory of Clinical Immunology and Microbiology, LCIM, National Institute of Allergy and Infectious Diseases, NIAID, National Institutes of Health, NIH, Bethesda, MD, USA.
  • Ehl S; Center for Chronic Immunodeficiency, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany; Center for Pediatrics and Adolescent Medicine, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
  • Rohr JC; Center for Chronic Immunodeficiency, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany; Center for Pediatrics and Adolescent Medicine, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany. Electronic address: jan.rohr@uniklinik-freiburg.de.
Clin Immunol ; 201: 30-34, 2019 04.
Article en En | MEDLINE | ID: mdl-30776520
ABSTRACT
Severe combined immunodeficiencies (SCID) comprise a group of genetic diseases characterized by abrogated development of T lymphocytes. In some case reports of atypical SCID patients elevated proportions of γδ T lymphocytes have been reported. However, it is unknown whether these γδ T cells modulate or reflect the patient's clinical phenotype. We investigated the frequency of elevated γδ T cell proportions and associations with clinical disease manifestations in a cohort of 76 atypical SCID patients. Increased proportions of γδ T lymphocytes were present in approximately 60% of these patients. Furthermore, we identified positive correlations between elevated proportions of γδ T cells and the occurrence of CMV infections and autoimmune cytopenias. We discuss that CMV infections might trigger an expansion of γδ T lymphocytes, which could drive the development of autoimmune cytopenias. We advocate that atypical SCID patients should be screened for elevated proportions of γδ T lymphocytes, CMV infection and autoimmune cytopenias.
Asunto(s)
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Inmunodeficiencia Combinada Grave / Infecciones por Citomegalovirus / Linfocitos Intraepiteliales / Enfermedades Hematológicas Tipo de estudio: Risk_factors_studies Límite: Humans Idioma: En Revista: Clin Immunol Asunto de la revista: ALERGIA E IMUNOLOGIA Año: 2019 Tipo del documento: Article País de afiliación: Alemania

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Inmunodeficiencia Combinada Grave / Infecciones por Citomegalovirus / Linfocitos Intraepiteliales / Enfermedades Hematológicas Tipo de estudio: Risk_factors_studies Límite: Humans Idioma: En Revista: Clin Immunol Asunto de la revista: ALERGIA E IMUNOLOGIA Año: 2019 Tipo del documento: Article País de afiliación: Alemania